Cullinan Associates’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.11M | Buy |
48,239
+1,200
| +3% | +$107K | 0.33% | 62 |
|
|
2025
Q4 | $3.72M | Sell |
47,039
-3,400
| -7% | -$267K | 0.25% | 75 |
|
|
2025
Q3 | $4.03M | Hold |
50,439
| – | – | 0.26% | 72 |
|
|
2025
Q2 | $4.58M | Hold |
50,439
| – | – | 0.3% | 66 |
|
|
2025
Q1 | $4.73M | Hold |
50,439
| – | – | 0.33% | 63 |
|
|
2024
Q4 | $4.59M | Sell |
50,439
-4,300
| -8% | -$410K | 0.29% | 67 |
|
|
2024
Q3 | $5.45M | Sell |
54,739
-70
| -0.1% | -$7.13K | 0.31% | 63 |
|
|
2024
Q2 | $5.32M | Sell |
54,809
-9,600
| -15% | -$886K | 0.3% | 68 |
|
|
2024
Q1 | $5.8M | Sell |
64,409
-1,800
| -3% | -$153K | 0.33% | 65 |
|
|
2023
Q4 | $5.28M | Sell |
66,209
-12,100
| -15% | -$910K | 0.29% | 79 |
|
|
2023
Q3 | $5.57M | Hold |
78,309
| – | – | 0.32% | 70 |
|
|
2023
Q2 | $6.03M | Sell |
78,309
-3,000
| -4% | -$232K | 0.33% | 75 |
|
|
2023
Q1 | $6.11M | Sell |
81,309
-4,151
| -5% | -$309K | 0.36% | 78 |
|
|
2022
Q4 | $6.73M | Buy |
85,460
+2,751
| +3% | +$206K | 0.37% | 61 |
|
|
2022
Q3 | $5.81M | Sell |
82,709
-2,800
| -3% | -$220K | 0.37% | 70 |
|
|
2022
Q2 | $6.85M | Sell |
85,509
-5,900
| -6% | -$461K | 0.42% | 66 |
|
|
2022
Q1 | $6.93M | Sell |
91,409
-700
| -0.8% | -$55.4K | 0.36% | 73 |
|
|
2021
Q4 | $7.86M | Hold |
92,109
| – | – | 0.4% | 72 |
|
|
2021
Q3 | $6.96M | Buy |
92,109
+50
| +0.1% | +$3.97K | 0.38% | 74 |
|
|
2021
Q2 | $7.49M | Buy |
92,059
+450
| +0.5% | +$36.8K | 0.42% | 75 |
|
|
2021
Q1 | $7.22M | Sell |
91,609
-1,100
| -1% | -$86.2K | 0.42% | 70 |
|
|
2020
Q4 | $7.93M | Hold |
92,709
| – | – | 0.48% | 57 |
|
|
2020
Q3 | $7.15M | Sell |
92,709
-38,940
| -30% | -$2.97M | 0.46% | 52 |
|
|
2020
Q2 | $9.64M | Sell |
131,649
-400
| -0.3% | -$28.4K | 0.68% | 32 |
|
|
2020
Q1 | $8.76M | Sell |
132,049
-4,600
| -3% | -$324K | 0.72% | 33 |
|
|
2019
Q4 | $9.41M | Sell |
136,649
-4,380
| -3% | -$299K | 0.63% | 43 |
|
|
2019
Q3 | $10.4M | Sell |
141,029
-100
| -0.1% | -$7.25K | 0.74% | 30 |
|
|
2019
Q2 | $10.1M | Sell |
141,129
-1,500
| -1% | -$106K | 0.73% | 32 |
|
|
2019
Q1 | $9.78M | Sell |
142,629
-100
| -0.1% | -$6.46K | 0.73% | 35 |
|
|
2018
Q4 | $8.49M | Sell |
142,729
-2,343
| -2% | -$147K | 0.7% | 34 |
|
|
2018
Q3 | $9.71M | Sell |
145,072
-1,407
| -1% | -$93.7K | 0.7% | 33 |
|
|
2018
Q2 | $9.49M | Sell |
146,479
-300
| -0.2% | -$19.6K | 0.73% | 32 |
|
|
2018
Q1 | $10.5M | Buy |
146,779
+53,699
| +58% | +$3.86M | 0.8% | 26 |
|
|
2017
Q4 | $7.02M | Sell |
93,080
-3,500
| -4% | -$256K | 0.52% | 48 |
|
|
2017
Q3 | $7.04M | Sell |
96,580
-710
| -0.7% | -$51.2K | 0.54% | 50 |
|
|
2017
Q2 | $7.21M | Sell |
97,290
-102,167
| -51% | -$7.59M | 0.56% | 48 |
|
|
2017
Q1 | $14.6M | Sell |
199,457
-12,632
| -6% | -$884K | 1.19% | 11 |
|
|
2016
Q4 | $13.9M | Buy |
212,089
+1,776
| +0.8% | +$122K | 1.18% | 12 |
|
|
2016
Q3 | $15.6M | Buy |
210,313
+1,223
| +0.6% | +$90.4K | 1.33% | 12 |
|
|
2016
Q2 | $15.3M | Sell |
209,090
-927
| -0.4% | -$66K | 1.24% | 12 |
|
|
2016
Q1 | $14.8M | Buy |
210,017
+6,378
| +3% | +$424K | 1.27% | 12 |
|
|
2015
Q4 | $13.6M | Buy |
203,639
+64,594
| +46% | +$4.3M | 1.18% | 15 |
|
|
2015
Q3 | $8.82M | Buy |
139,045
+6,875
| +5% | +$449K | 0.81% | 25 |
|
|
2015
Q2 | $8.64M | Buy |
132,170
+3,900
| +3% | +$265K | 0.71% | 29 |
|
|
2015
Q1 | $8.89M | Sell |
128,270
-67,049
| -34% | -$4.63M | 0.69% | 30 |
|
|
2014
Q4 | $13.5M | Buy |
195,319
+42,219
| +28% | +$2.85M | 1.43% | 9 |
|
|
2014
Q3 | $9.98M | Buy |
153,100
+70,576
| +86% | +$4.65M | 1.14% | 14 |
|
|
2014
Q2 | $4.73M | Sell |
82,524
-55,926
| -40% | -$3.75M | 0.77% | 17 |
|
|
2014
Q1 | $8.98M | Buy |
138,450
+7,700
| +6% | +$485K | 1.02% | 17 |
|
|
2013
Q4 | $8.53M | Buy |
130,750
+2,876
| +2% | +$184K | 0.99% | 15 |
|
|
2013
Q3 | $7.58M | Buy |
127,874
+9,416
| +8% | +$558K | 1.02% | 12 |
|
|
2013
Q2 | $6.79M | Buy |
+118,458
| New | +$7.03M | 0.92% | 16 |
|
Other funds holding CL
VCM
DAM
VPM
Cullinan Associates's CL Position: Q1 2026 in Review
Cullinan Associates increased its Colgate-Palmolive (CL) stake by 2.6% in Q1 2026, buying an estimated $107K and bringing the position to 48,239 shares worth $4.11M. The position accounts for 0.33% of the portfolio, ranked #62.
Cullinan Associates first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.6M in Q3 2016. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Cullinan Associates held 48,239 shares of Colgate-Palmolive worth $4.11M as of Q1 2026.
- Cullinan Associates bought 1,200 Colgate-Palmolive shares in Q1 2026, an estimated $107K.
- Colgate-Palmolive made up 0.33% of Cullinan Associates's portfolio in Q1 2026, its #62 holding.
- Cullinan Associates first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
- Cullinan Associates's Colgate-Palmolive position peaked at $15.6M in Q3 2016.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Cullinan Associates's 13F filing for Q1 2026, filed 1 May 2026.